NR4A1 and breast carcinoma: In this context, the most widely used breast cancer markers are estrogen (ER) and progesterone (PR) hormonal receptors, human epidermal growth factor receptor-2 proto-oncogene (Her-2/neu or c-erbB-2), ki-67 antigen and p53 protein [1,8–10].